Literature DB >> 10584794

Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT.

M E O'Malley1, G W Boland, B J Wood, C Fernandez-del Castillo, A L Warshaw, P R Mueller.   

Abstract

OBJECTIVE: This study was conducted to evaluate newly introduced criteria for unresectability of pancreatic cancer with thin-section pancreatic-phase helical CT.
MATERIALS AND METHODS: Twenty-five patients with adenocarcinoma in the head of the pancreas underwent thin-section pancreatic-phase helical CT. The major peripancreatic vessels were categorized on a scale of 1-4, according to the degree of circumferential involvement by tumor. The maximum diameters of the small peripancreatic veins--gastrocolic trunk, anterosuperior pancreaticoduodenal vein, and posterosuperior pancreaticoduodenal vein--were recorded. Findings on CT were compared with the results of surgery in each patient.
RESULTS: Sixteen patients had surgically resectable tumors, and nine patients had surgically unresectable tumors. CT and surgical correlation was available for 98 major peripancreatic vessels; 85 were resectable and 13 were unresectable. Of category 1 vessels, 72 (97%) of 74 were resectable at surgery. Of category 2 vessels, 12 (71%) of 17 were resectable. One (50%) of two category 3 vessels and none (0%) of five category 4 vessels were resectable at surgery. CT showed a dilated gastrocolic trunk in two patients; one of these patients had a surgically resectable tumor, but the other patient had a surgically unresectable tumor.
CONCLUSION: In patients with adenocarcinoma in the head of the pancreas, the degree of circumferential vessel involvement by tumor as shown by CT is useful in predicting which patients will have surgically unresectable tumors. A dilated gastrocolic trunk should not be used as an independent sign of surgical unresectability.

Entities:  

Mesh:

Year:  1999        PMID: 10584794     DOI: 10.2214/ajr.173.6.10584794

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  31 in total

1.  The role of MRI in pancreatic cancer.

Authors:  Philip A Robinson
Journal:  Eur Radiol       Date:  2001-10-16       Impact factor: 5.315

Review 2.  Multidetector CT and three-dimensional imaging of the pancreas: state of the art.

Authors:  Karen M Horton
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

3.  Vascular involvement in pancreatic neoplasm: a comparison between spiral CT and DSA.

Authors:  Ettore Squillaci; Ezio Fanucci; Francesco Sciuto; Salvatore Masala; Giulio Sodani; Marco Carlani; Giovanni Simonetti
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

4.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 5.  Vascular anatomy of the pancreas and clinical applications.

Authors:  K Ibukuro
Journal:  Int J Gastrointest Cancer       Date:  2001

6.  Correlation of CT enhancement, tumor angiogenesis and pathologic grading of pancreatic carcinoma.

Authors:  Zhong-Qiu Wang; Jie-Shou Li; Guang-Ming Lu; Xin-Hua Zhang; Zi-Qian Chen; Kui Meng
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Assessment of vascular invasion in pancreatic head cancer with multislice spiral CT: value of multiplanar reconstructions.

Authors:  Melanie Brügel; Thomas M Link; Ernst J Rummeny; Peter Lange; Jörg Theisen; Martin Dobritz
Journal:  Eur Radiol       Date:  2004-04-09       Impact factor: 5.315

Review 8.  Staging cancer of the pancreas.

Authors:  G Morana; L Cancian; R Pozzi Mucelli; C Cugini
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

9.  Surgical resectability of pancreatic adenocarcinoma: CTA.

Authors:  Jimmie C Wong; Steven Raman
Journal:  Abdom Imaging       Date:  2009-05-26

Review 10.  Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI).

Authors:  Isaac R Francis
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.